Cross-sectional study of prevalence and determinants of uncontrolled hypertension among South African adult residents of Mkhondo municipality by Masilela, Charity Mandisa et al.
RESEARCH ARTICLE Open Access
Cross-sectional study of prevalence and
determinants of uncontrolled hypertension
among South African adult residents of
Mkhondo municipality
Charity Masilela1* , Brendon Pearce1, Joven Jebio Ongole2, Oladele Vincent Adeniyi3 and Mongi Benjeddou1
Abstract
Background: Achieving the blood pressure treatment target in individuals with hypertension is a serious global
health challenge. Furthermore, the actual burden of uncontrolled hypertension is poorly understood, especially in
the developing countries. Therefore, this study comprehensively examined the prevalence and factors associated
with uncontrolled hypertension in individuals receiving care at the primary healthcare facilities in the rural areas of
Mkhondo Municipality in the Mpumalanga Province, South Africa.
Methods: In this cross-sectional study, 329 individuals attending care for hypertension were recruited from January
2019 to June 2019 at three primary healthcare centres, namely, Piet Retief hospital, Mkhondo town clinic and
Thandukukhanya community health centre. Uncontrolled hypertension was defined as systolic blood pressure ≥
140 mmHg and/or diastolic blood pressure ≥ 90 mmHg in accordance with the South African Hypertension Society
guideline (2014). Multiple logistic regression (Forward LR method) analysis was used to identify the significant
determinants of uncontrolled hypertension.
Results: The majority of the participants were 55 years old and above (69.0%), Zulus (81.2%), non-smokers
(84.19%) and had been diagnosed with hypertension for more than a year prior to the study (72.64%). The
overall prevalence of uncontrolled hypertension was 56.83% (n = 187) with no significant difference between
sexes, 57.38% male versus 56.88% female, respectively. In the multiple logistic regression model analysis after
adjusting for confounding variables, obesity (AOR = 2.90; 95% CI 1.66–5.05), physical activity (AOR = 4.79; 95%
CI 2.15–10.65) and HDL-C (AOR = 5.66; 95% CI 3.33–9.60) were the significant and independent determinants
of uncontrolled hypertension in the cohort.
Conclusion: The high prevalence of uncontrolled hypertension in the study setting can be largely attributed
to obesity, physical activity and dyslipidaemia. Treatment will require the collaborative efforts of individuals,
clinicians and health authorities. All these determinants should be addressed decisively so as to achieve the
treatment blood pressure targets in the study population.
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Background
The prevalence of non-communicable diseases (NCDs)
is increasing at an alarming rate world-wide and it has
been driven by the rise in the incidence of cardiovascular
risk factors such as obesity, diabetes and hypertension
[1]. Hypertension is one of the important risk factors for
morbidity and mortality, affecting about 1 billion people
world-wide [2]. In the year 2000, 972 million people
were living with hypertension and a large burden was
borne by economically disadvantaged countries [2],
where awareness and treatment often fall short. Accord-
ing to the World Health Organization (WHO), 27.4% of
men and 26.1% of women have hypertension [3],
although an overall prevalence of up to 54% has been re-
ported in urban areas [4]. In the absence of effective
intervention strategies to control this epidemic, the
prevalence of hypertension is likely to increase in the
next decade [2, 4].
Hypertension is a multifactorial and highly complex
disease that is characterized by a systolic blood pres-
sure ≥ 140 mmHg and/ or diastolic blood pressure ≥ 90
mmHg [5]. The risk factors of hypertension include ex-
cessive salt intake [6], alcohol consumption and lack of
physical activity [7]. Evidence suggests that hypertension
has no obvious symptoms and often remains undiag-
nosed for a long period [8]. Furthermore, the asymptom-
atic and persistent nature of the disease presents a major
challenge of identifying people with elevated blood pres-
sure and providing optimal medical care [8]. When diag-
nosed early, lifestyle changes and pharmacological
interventions are essential for the management and con-
trol of the disease [8, 9]. However, poor adherence to
non-pharmacological and pharmacological management
of hypertension represents a serious challenge for public
health in many countries [10, 11].
Uncontrolled hypertension, defined as blood systolic
blood pressure ≥ 140 and / or diastolic blood pressure ≥
90mmHg, has been associated with patients’ aging, clin-
ical inertia, unemployed status and nutritional transi-
tions [12]. Furthermore, only 25% of individuals
undergoing anti-hypertensive treatment appear to be
well controlled [9], while the majority of studies con-
ducted in Africa have shown that less than a third of pa-
tients reach their treatment goals [13]. In South Africa,
the prevalence of uncontrolled hypertension has been
estimated at between 13.5–75.5% [12, 14], whilst figures
ranging between 19.0–56.0% have been reported for
hypertension control [3]. On the other hand, hyperten-
sion control among individuals residing in high-income
countries has been reported as being as high as 82.0% [3,
15], whereas a number as low as 28.4% has also been re-
ported in high-income countries [16]. Those who fail to
reach therapeutic targets continue to be at higher risk of
cardiovascular events, kidney diseases [9, 17], stroke
[18], metabolic syndrome, hypertensive retinopathy [19]
and dementia [20]. In addition to adherence, the multi-
factorial nature of hypertension presents the greatest
challenge for its treatment and control [21]. Even so,
only a few studies have assessed the prevalence of un-
controlled hypertension and its determining factors in
South Africa, particularly within economically disadvan-
taged populations. As a result, the actual burden of un-
controlled hypertension in such communities is poorly
understood and, awareness as well as treatment to
achieve control, remains suboptimal. Therefore, epi-
demiological data from these communities are essential
in planning interventions based on local influential fac-
tors associated with the disease. On these grounds, the
current study aims to comprehensively assess the preva-
lence, the socio-demographic and clinical determinants
of uncontrolled hypertension among patients receiving
health care in three public sector facilities serving the
rural areas of Mkhondo municipality in the Mpumalanga
province, South Africa.
Methods
Study design and settings
This was a community based cross-sectional study con-
ducted in the Piet Retief Hospital, Mkhondo town clinic
and Thandukukhanya Community Health Center in
Mkhondo Municipality of Mpumalanga Province, South
Africa, from January 2019 to June 2019. These health
care facilities provide chronic care services for the resi-
dents of Mkhondo Municipality. Mkhondo is located in
the Gert Sibande district of the Mpumalanga province
and is a resource-constrained community made up of a
small town surrounded by farms and two townships
(Ethandukukhanya and AJAX) with a population of ap-
proximately 189,036 [22].
Study population and sample size estimation
The study included individuals who were aged ≥18 years,
had been diagnosed and initiated on treatment for
hypertension at least a year prior to the study. Individ-
uals who were bedridden, mentally compromised, preg-
nant or unable to give consent were excluded from the
study.
A sample size of 334 was estimated by using the for-
mula for cross-sectional study:
N ¼ Z1αð Þ2x P 1−Pð Þ=D2
 
Given that the prevalence of uncontrolled hyperten-
sion ranged widely from 13.5–75.5% in South Africa [12,
14], P (P = proportion with uncontrolled hypertension)
of 68% was chosen for the sample size estimation. Z1 –
α = 1.96 and D = absolute precision, which is taken as
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0.05. Five participants dropped out of the study so a
total of 329 patients were included in the final analysis.
Data collection
Eligible participants were recruited sequentially at the
study settings over the study period. Trained research as-
sistants conducted face-to-face interviews with consenting
participants by using a standardized questionnaire (Sup-
plementary file). The questionnaire comprises socio-
demographic characteristics of age, sex, level of education
and employment status, lifestyle behaviors; physical activ-
ity and dietary patterns; cigarette smoking status and
alcohol use; plus, questions about family history of hyper-
tension. The following clinical data were obtained from
the medical records: duration of hypertension, number of
anti-hypertensive drugs and drug combinations. Drug
combinations included the following: Thiazide diuretic
only, combination therapy (Thiazide + calcium channel
blocker + Angiotensin converting enzyme inhibitor and
Thiazide + calcium channel blocker + Angiotensin con-
verting enzyme inhibitor + beta-blocker) and other (Loop
diuretic monotherapy, loop diuretic + calcium channel
blocker and/ or beta-blocker + calcium channel blocker +
Angiotensin converting enzyme inhibitor).
The level of education was categorized as no educa-
tion, primary (grade 1–6), secondary (7–12) and tertiary.
Employment status was categorized as unemployed,
employed or receiving social grants from the govern-
ment. Smoking status were categorized as never smoked
or ever smoked; while alcohol use was also categorized
similarly. Physical activity was categorized as active (if
engaging in vigorous intensity exercise leading to an in-
crease in heart and respiratory rate, such as gardening,
or inactive (not engaging in any physical activity). Also,
participants reported their average consumption of fruits
and vegetables, as well as fast food and salt intake.
A trained research nurse conducted anthropometric
measurements of weight to the nearest 0.1 kg using a
digital scale (Tanita-HD 309, Creative Health Products,
MI, USA) and height to the nearest of 0.1 cm using a
mounted stadiometer. All measurements were taken
with the participants wearing minimal clothing and no
shoes. Body Mass Index (BMI) for each patient was cal-
culated as weight (kg) divided by height in meters
squared (m2) and was categorized based on WHO cri-
teria as obese (30 or greater kg/ m2) or not [23].
Blood pressure (BP) was measured using a validated
automated digital blood pressure monitor (Macrolife BP
A 100 Plus model) according to standard protocols. The
BP was recorded in triplicate and the average was used
for analysis. Patients with systolic BP (SBP) of ≥140
mmHg and/ or diastolic BP (DBP) ≥ 90mmHg were de-
fined as uncontrolled BP [24].
Laboratory assessment
Patients participated in an 8 h fast before the research
nurse drew five millilitres of venous blood from each of
them as a sample for laboratory assessment. The lipid
profile, which includes total cholesterol (TC), triglycer-
ides (TG), low-density lipoprotein (LDL-C) and high-
density lipoprotein (HDL-C)] for each participant, was
categorized according to the guidelines of The Society
for Endocrinology, Metabolism and Diabetes of South
Africa (SEMDSA, 2017). All laboratory assays were con-
ducted by the National Health Laboratory Services
(NHLS) of Piet Retief and Ermelo Provincial hospitals in
accordance with standard protocols.
Statistical analysis
Data analysis was conducted using IBM SPSS Statistics
for Windows, Version 25.0 (IBM Corp., Armonk, New
York, USA). General characteristics of the participants
were expressed as mean ± standard deviation for con-
tinuous variables. Categorical variables were reported as
frequency (percentage). The associations between socio-
demographic-, clinical factors and uncontrolled hyper-
tension were examined by using bivariate analysis. Mul-
tiple logistic regression odds ratios and their 95%
confidence intervals, using crude and adjusted logistic
regression model analysis, helped identify the independ-
ent determinants of uncontrolled hypertension. A p-
value of less than 0.05 was considered statistically
significant.
Results
Of the total number of participants (n = 329), 61 were
males (18.5%) and 268 were females (81.5%). The major-
ity of the participants were aged 55 years and above
(69.0%), of Zulus origin (81.2%), non-smokers (84.19%),
non-alcohol drinkers (77.81%), consuming fruit and veg-
etables (97.87%) and fast food about three times per
week (61.09%), which differed according to sex. A seden-
tary lifestyle was reported by 231 participants (70.21%);
22 were males and 209 were females. Consumption of
excessive amounts of salt was reported by 42 partici-
pants (12.78%) of whom a higher proportion were
women (n = 37) in comparison with men (n = 5). The
majority of the participants who had been diagnosed
within the previous 5 years (n = 234; 72.64%) were pre-
dominantly women (n = 194). Table 1 provides detailed
descriptive characteristics of the participants.
Prevalence of uncontrolled hypertension
All the participants (N = 329) had been on anti-
hypertensive treatment for at least a year. The majority
of the participants were on at least two or more anti-
hypertensive drugs (n = 260; 79.03%). Thiazide diuretic
(for example, hydrochlorothiazide) was the preferred
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All 329 (100%) 142 (43.16%) 187 (56.83%)
Gender 0.925
Male 61 (18.54) 26 (18.31) 35 (18.72)
Female 268 (81.46) 116 (81.69) 152 (81.28)
Age (Years) 0.467
18–25 08 (2.43) 03 (2.11) 05 (2.67)
26–35 13 (3.95) 05 (3.52) 08 (4.28)
36–45 29 (8.81) 08 (5.63) 21 (11.22)
46–55 69 (20.97) 32 (22.54) 37 (19.78)
56–65 97 (29.48) 47 (33.09) 50 (26.73)
≥ 66 113 (34.35) 47 (33.09) 66 (35.29)
Ethnicity 0.813
Zulu 267 (81.16) 114 (80.28) 153 (81.81)
Swati 54 (16.41) 24 (16.90) 30 (16.04)
Not specified 08 (2.43) 4 (2.82) 4 (2.14)
Employment status 0.201
Employed 79 (24.01) 39 (27.46) 40 (21.39)
Unemployed 104 (31.61) 38 (26.76) 66 (35.29)
Social grant recipient 146 (44.38) 65 (45.80) 81 (43.32)
Educational Level 0.157
Tertiary 07 (2.13) 05 (3.52) 02 (1.07)
Secondary 109 (33.13) 46 (32.39) 63 (33.68)
Primary 140 (42.55) 54 (38.03) 86 (45.98)
Illiterate 73 (22.19) 37 (26.05) 36 (19.26)
Smoking status 0.634
Never Smoked 277 (84.19) 118 (83.09) 159 (85.03)
Ever Smoked 52 (15.81) 24 (16.91) 28 (14.97)
Alcohol consumption 0.922
Never Drank 254 (77.20) 110 (77.46) 144 (77.01)
Occasional 75 (22.80) 32 (22.54) 43 (22.99)
Fruit and Vegetable Consumption 0.987
1–3 times/week 322 (97.87) 139 (97.89) 183 (97.86)
Never 07 (2.13) 03 (2.11) 04 (2.14)
Fast Food Consumption 0.459
Never 128 (38.91) 52 (36.62) 76 (40.64)
1–3 times/week 201 (61.09) 90 (63.38) 111 (59.36)
Salt intake 0.771
Low-Moderate 287 (87.23) 123 (86.62) 164 (87.70)
Increased 42 (12.77) 19 (13.38) 23 (12.30)
Duration of Diagnosis 0.140
< 5 years 95 (28.88) 35 (24.65) 60 (32.09)
≥ 5 years 234 (71.12) 107 (75.35) 127 (67.91)
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drug class, either alone (n = 44; 13.37%) or in combin-
ation with other drugs (calcium channel blockers, beta-
blockers and Angiotensin-converting enzyme inhibitors)
(86.62%). Successful treatment of reaching the blood
pressure target of 140/90 mmHg occurred in 142 pa-
tients (43.62%) of the 329 participants. The overall
prevalence of uncontrolled hypertension was 56.83%
(n = 187), with no significant difference between sexes:
57.38% males versus 56.88% females, respectively
(Fig. 1).
Factors associated with uncontrolled hypertension
In the bivariate logistic regression analysis (Table 2),
physical activity (p < 0.001), positive family history (p =
0.034), low HDL-C (p < 0.001) and obesity (p = 0.001)
were significantly associated with uncontrolled hyperten-
sion. Other risk factors such as age, gender, smoking sta-
tus, alcohol consumption, Total cholesterol, LDL-C and
triglycerides were not significantly associated with un-
controlled hypertension (p > 0.05).
In the multiple logistic (crude and adjusted) regression
model analysis (Table 3), the categories were merged to
create a binary outcome for each of the variables,
namely, education, employment and age. In the final
model, obesity (1.29–3.20), physical activity (1.56–4.75),
low HDL-C (3.21–8.30), combination regimen (Thiazide,
calcium channel blockers and Angiotensin converting
enzyme inhibitors) (1.01–3.17) and being on two (0.09–
0.83) or three drugs (0.11–0.95) were the independent
and significant determinants of uncontrolled hyperten-
sion. However, after adjusting for confounding factors
(level of education, ethnicity, smoking status, alcohol
use, fruit and vegetable consumption, family history of
hypertension, total cholesterol, triglycerides and LDL-C),
obesity (1.66–5.05), physical activity (2.15–10.65) and
low HDL-C (3.33–9.60) were the significant and inde-
pendent determinants of uncontrolled hypertension in
the cohort. Individuals who were obese were three times
more likely to have uncontrolled hypertension compared
to those who were not. Likewise, participants who were
physically active were close to five times more likely to
have uncontrolled hypertension compared to those who
were physically inactive. Individuals with low HDL-C
were close to six times more likely to have uncontrolled
hypertension compared to those with normal HDL-C.
Discussion
Hypertension is an independent risk factor for cardiovas-
cular diseases and all causes of premature deaths [2, 7,
18]. As such, the control of hypertension is essential in
lowering cardiovascular and mortality risk in patients
[18, 21]. However, the prevalence and factors that deter-
mine uncontrolled hypertension in rural communities of
South Africa are understudied and the actual burden of
the disease is poorly understood. This study therefore
aimed to assess the prevalence, socio-demographic- and
clinical determinants of uncontrolled hypertension
among patients receiving healthcare in three government
facilities serving the rural areas of Mkhondo municipal-
ity in the Mpumalanga province, South Africa.
South Africa has the highest prevalence of hyperten-
sion in Southern Africa [4]. Despite the high prevalence,
Fig. 1 Prevalence of Uncontrolled hypertension
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the level of awareness and control of the disease is low
among impoverished communities [3]. In the current
study, the overall prevalence of uncontrolled hyperten-
sion was 56.83%. In comparison to other studies con-
ducted in Africa, the figure presented in this study was
slightly lower than those reported in Zimbabwe (61.0%)
[25] and Nigeria (60.0%) [26], but higher than the 52.7%
reported in Ethiopia [27]. In comparison to other studies
conducted in different parts of South Africa, the result is
lower than the 75.5% that was reported in the rural East-
ern Cape province [12]; however, it is higher than the
13.5% prevalence that was reported in the South African
National Health and Nutrition Examination Survey [14].
It is important to note that the wide disparity observed
between the two results can be explained by the large
sample of non-hypertensive individuals in the national
survey, whilst the current study was exclusive to hyper-
tensive patients.







Negative 90 (63.38) 132 (70.59) 1
Positive 52 (36.62) 55 (29.41) 1.91 (1.04–3.49) 0.034
Total Cholesterol
< 5.2 mmol/L 101 (71,13) 131 (70.05) 1
≥ 5.2 mmol/L 41 (28.87) 56 (29.94) 1.12 (0.53–2.37) 0.759
HDL-C
≥ 1 mmol/L 100 (70.42) 59 (31.55) 1
< 1mmol/L 42 (29.58) 128 (68.45) 0.13 (0.07–0.24) < 0.001
LDL-C
< 2.6 mmol/L 69 (48.59) 86 (45.99) 1
≥ 2.6 mmol/L 73 (51.41) 101 (54.01) 0.83 (0.42–1.64) 0.596
Triglycerides
< 1.7 mmol/L 65 (45.77) 74 (39.57) 1
≥ 1.8 mm0/L 77 (54.23) 113 (60.43) 0.74 (0.40–1.37) 0.342
Drug combinations
Thiazide 23 (16.20) 21 (11.23) 1
Thiazide+CCB + ACEI 23 (16.19) 47 (25.13) 1.37 (0.40–4.72) 0.610
Thiazide+CCB + ACEI+β-blocker 04 (2.82) 14 (7.49) 0.65 (0.20–2.14) 0.485
Other 92 (64.79) 105 (56.15) 5.09 (0.15–173.39) 0.366
Number of Drugs
1 38 (26.76) 31 (16.58) 1
2 69 (48.59) 68 (36.36) 1.13 (0.04–32.33) 0.943
3 30 (21.13) 73 (39.04) 1.55 (0.06–39.10) 0.788
4 05 (3.52) 15 (8.02) 6.33 (0.22–181.92) 0.281
Diabetes
No 80 (56.34) 116 (62.03) 1
Yes 62 (43.66) 71 (37.97) 1.18 (0.65–2.14) 0.587
Obesity
No 66 (46.48) 56 (29.95) 1
Yes 76 (53.52) 131 (70.05) 0.35 (0.19–0.66) 0.001
Physical Activity
Inactive 121 (85.21) 127 (67.91) 1
Active 21 (14,79) 60 (32.09) 0.18 (0.08–0.43) < 0.001
HDL-C High density lipoprotein cholesterol; LDL-C Low density lipoprotein cholesterol
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In the current study, the presence of obesity was sig-
nificantly associated with uncontrolled hypertension.
These findings are supported by studies conducted in
Ethiopia [13, 27], China [28] and Zimbabwe [29], where
excessive body weight was statistically associated with
the incidence of uncontrolled hypertension [28, 29].
Moreover, it has been shown that a modest weight-loss
will not only decrease blood pressure, but will also have
a favorable impact on obesity related risk factors [29,
30]. Obesity is traditionally defined as the abnormal ac-
cumulation of body fat ≥20% over the individual’s ideal
body weight and assessed as BMI ≥ 30 kg/m2 [29]. The
increasing prevalence of obesity has been identified as
the most important risk factor for a number of life
threatening conditions, including hypertension [31, 32].
Patients with obese-related hypertension often present
with increased blood volume, high levels of circulating
aldosterone, insulin resistance and obstructive sleep
apnea syndrome [33, 34]. A number of studies have
identified that there is a direct and apparent dose-
response relationship between an increase in BMI and
blood pressure [35].
In the current study, engagement in physical activity
was associated with the higher odds of having uncon-
trolled hypertension. It should be noted that the activity
level of the participants was obtained by self-report and
there was no standardized measure of the intensity of
the physical activity. In addition, there is a lack of formal
recreational centres (gymnasium) for graded exercises in
the study setting. Also, other risk factors, such as exces-
sive salt intake, may have masked the beneficial effect of
exercise on blood pressure control in this population. A
study conducted in Ethiopia showed that non-adherence
to physical activity was associated with uncontrolled
hypertension [13]. In addition, a study conducted in
China showed that lack of physical activity was signifi-
cantly associated with uncontrolled hypertension [28].
The exact mechanism through which physical activity al-
leviates high blood pressure has not yet been fully eluci-
dated. In addition, optimal prescription of physical
activity for hypertension control is not known. Current
hypotheses suggest that there is a link between hyper-
tension control and alterations in insulin sensitivity,
autonomic nervous system function and vasoconstriction
regulation [13]. There seems to be more evidence sup-
porting the beneficial effects of physical activity on
hypertension prevention than those refuting it. Engage-
ment in physical activity for at least 30–45 min, five
times per week is associated with a lower incidence of
hypertension [36]. In the last few decades, there has
been a great deal of evidence on the protective effect of
physical activity on the development of hypertension
[36, 37]. As a result, physical activity has become the
most common lifestyle modification that is often
Table 3 Adjusted and unadjusted logistic regression models







Male 1.03 (0.59–1.80) 1.00 (0.51–1.94)
Female 1 1
Age
< 55 0.94 (0.59–1.51) 0.85 (0.48–1.48)
≥ 55 1 1
Employment status
Unemployed 1.49 (0.93–2.41) 1.47 (0.83–2.62)
Employed 1 1
Duration since diagnosis
> 5 years 0.69 (0.42–1.13) 1.99 (0.94–4.20)
5 years and below 1 1
Salt intake
Increased 0.91 (0.47–1.74) 1.64 (0.72–3.71)
Low-Moderate 1 1
Diabetes
Yes 0.79 (0.51–1.23) 0.86 (0.50–1.48)
No 1 1
Obesity
Yes 2.03 (1.29–3.20)* 2.90 (1.66–5.05)***
No
Physical Activity
Active 2.72 (1.56–4.75)*** 4.79 (2.15–10.65)***
Inactive 1 1
HDL-C
< 1mmol/L 5.17 (3.21–8.30)*** 5.66 (3.33–9.60)***
≥ 1 mmol/L 1 1
Drug Combinations
Thiazide 0.80 (0.42–1.54) 1.32 (0.42–4.12)
Thiazide+CCB + ACEI 1.79 (1.01–3.17)* 0.67 (0.23–1.92)
Thiazide+CCB +
ACEI+ β-Blocker
3.07 (0.98–9.64) 2.00 (0.07–57.94)
Other 1 1
Number of Drugs
1 0.27 (0.09–0.83)* 0.38 (0.02–9.92)
2 0.33 (0.11–0.95)* 0.54 (0.02–12.44)
3 0.81 (0.27–2.43) 1.71 (0.07–43.64)
4 1 1
***p-values < 0.001; *p-values< 0.05; CI Confidence Interval; HDL-C High density
lipoprotein cholesterol; LDL-C Low density lipoprotein cholesterol
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recommended after an individual has been diagnosed
with hypertension [37].
Furthermore, the current study found an association be-
tween decreased HDL-C (< 1mmol/L) (dyslipidaemia)
and uncontrolled hypertension. Dyslipidemia comprises
having an abnormality in LDL-cholesterol, HDL-
cholesterol and triglyceride levels [38]. Abnormalities in
lipid levels are believed to be key players in the develop-
ment of coronary heart disease and may be present long
before other risk factors occur [38]. Also, the co-existence
of hypertension and dyslipidemia is often observed in clin-
ical practice [39] and the risk of cardiovascular events in
individuals with concomitant hypertension and dyslipid-
emia is increased [38, 40]. A recent study demonstrated
that low HDL-C levels are associated with an increased
risk of hypertension [41]. These findings were similar to
observations made in a study conducted in the United
States of America, where low levels of HDL-C among the
elderly were associated with hypertension and an in-
creased risk of cardiovascular disease [42]. To date, pro-
spective studies that have demonstrated the relationship
between controlled blood pressure and plasma lipid levels,
particularly HDL-C, are lacking. Therefore, the finding of
the association between low HDL-C and uncontrolled
hypertension in the present study requires further
investigations.
Anti-hypertensive drugs are prescribed mainly to re-
duce blood pressure and complications associated with
the disease. Studies have shown that following clinical
guidelines in practice improves the treatment outcomes
[43]. Additionally, clinical guidelines, including the
South African hypertension guideline, recommend the
use of multiple drugs to effectively control blood pres-
sure and reduce the possibility of hypertension-related
complications [24]. It is important to note that all the
participants in this study had been on anti-hypertensive
therapy for at least a year before the commencement of
the study. The high prevalence of uncontrolled hyper-
tension occurred, irrespective of the number of drugs
and combinations administered. A plausible explanation
could be non-adherence to treatment among the study
participants. However, the level of adherence to treat-
ment was not explored in the current study. Irrespective
of the findings in this study, it is important for clinicians
to follow evidence-based guidelines in prescribing anti-
hypertensive drugs in order to improve treatment out-
comes in these patients.
Limitations
This study has provided very important insights into the
treatment outcome (blood pressure) of individuals at-
tending health facilities for hypertension in the region,
but the limitations of the study cannot be ignored.
Causal association of the determinants cannot be
ascertained, given the cross-sectional design method
adopted in the study. Also, the lifestyle assessment
depended largely on self-report measures which can be
subject to social desirability bias. In addition, the urinary
sodium excretion level could have added more objectiv-
ity about the consumption of salts among the study
participants.
Conclusion
We found a high prevalence of uncontrolled hypertension
in the study setting, possibly attributed to obesity, physical
activity and dyslipidaemia. All these determinants should
be addressed decisively through collaborative efforts of in-
dividuals, clinicians and health authorities. Such collabor-
ation would facilitate achieving the treatment blood
pressure targets in the study population. To the best of
our knowledge, this study is the first to report the preva-
lence of uncontrolled hypertension with an association be-
tween it and low HDL-C, inadequate physical activity plus
obesity among residents of Mkhondo municipality. Fur-
thermore, this study has highlighted the need to imple-
ment more aggressive health strategies targeting the
identified determinants as well as blood pressure of the
patients in order to improve the overall outcomes of care
in the rural communities of Mkhondo municipality of
Mpumalanga province.
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